Business Context and Reporting Period
Company: Flora Growth Corp. (FLGC)
Filing Type: Form 8-K (Current Report)
Date of Report: September 19, 2025
Reporting Period: Events occurring September 19–20, 2025.
Context: The Company is executing a strategic pivot from its legacy hemp and cannabis business to a digital asset treasury strategy focused on the $0G token (native to the 0G Chain, a layer-1 blockchain for decentralized AI). This filing details a series of private placements, a major asset disposition, and significant changes to executive leadership.
Key Financial Metrics and Capital Structure
The filing outlines four distinct capital raising and restructuring transactions with the following aggregate values:
- Cash Private Placement: Net proceeds of approximately US$13.66 million from the sale of 116,340 common shares and 425,929 pre-funded warrants.
- Token Private Placement: Net proceeds valued at approximately US$215.30 million (based on 71.77 million Tokens received at a deemed value of $3.00 per Token).
- Note Private Placement (Solana): Unsecured convertible note with a principal value of US$22.88 million (95,333.33 Solana).
- Zero Gravity Private Placement: Unsecured convertible note with a principal value of US$150.00 million (50 million Tokens).
- Debt Repayment/Disposition: Transfer of legacy hemp/cannabis assets to repay promissory notes with an aggregate outstanding balance of US$2.22 million.
Liquidity and Use of Proceeds: Proceeds are designated for the digital asset treasury strategy, expanding AI functionality, and general working capital. The Company intends to file a Form S-3 for resale registration of securities within six months of shareholder approval.
Material Changes Versus Prior Period
- Strategic Pivot: The Company is divesting its entire hemp and cannabis-related business (the "Disposition") to focus exclusively on digital assets and AI infrastructure.
- Leadership Overhaul:
- Resignations: Clifford Starke (CEO and Director) and Sammy Dorf (Executive Chairman) resigned on September 20, 2025, citing no disagreement with the Company.
- Appointments: Daniel Reis-Faria appointed CEO and Director; Michael Heinrich appointed Executive Chairman and Director. Both bring expertise in AI and cybersecurity.
- Capital Structure: Significant dilution and debt issuance occurred via the private placements, introducing substantial exposure to cryptocurrency valuations ($0G and Solana).
Guidance, Outlook, Risks, and Unusual Items
Outlook and Strategy: Management intends to leverage the $0G token's native AI functionality to enhance business operations. The Company is transitioning to a "digital asset treasury" model.
Executive Compensation: New employment agreements for the CEO, CFO, and Executive Chairman include base salaries ranging from $350,000 to $600,000. Equity incentives (stock options) are heavily performance-based, vesting only if the Company's Volume Weighted Average Price (VWAP) reaches targets between $40.80 and $95.20. Severance packages include up to 30 months of base salary upon termination without cause or change in control.
Risks and Contingencies:
- Valuation Risk: Proceeds from the Token and Zero Gravity placements are valued based on a mutually agreed $3.00 per Token, which may differ from market trading prices.
- Regulatory Approval: Conversion of pre-funded warrants and notes into common shares requires shareholder approval under Nasdaq Listing Rules.
- Transaction Closing: The Zero Gravity Convertible Note is subject to an "Outside Date" of October 22, 2025; failure to close by this date results in automatic termination of the new agreement, reverting to a prior loan arrangement.
- Pro Forma Financials: The filing includes unaudited pro forma financial statements reflecting the disposition of the cannabis business as if it occurred on June 30, 2025, but explicitly states these are not indicative of future results.
Investor Verification Checklist
- Shareholder Approval: Verify the status of the upcoming shareholder meeting required to approve the issuance of pre-funded warrant shares and warrant shares.
- Token Valuation: Confirm the current market trading price of the $0G token versus the $3.00 deemed value used in the private placement.
- Asset Disposition Closing: Monitor the closing of the Equity Transfer and Debt Repayment Agreement to ensure the legacy cannabis assets are successfully transferred and the $2.22 million debt is extinguished.
- Convertible Note Terms: Review the specific conversion ratios and interest payment terms (payable in-kind or cash) for the Solana and Token-denominated notes.
- Executive Vesting: Assess the feasibility of the new executive stock option vesting triggers (VWAP targets up to $95.20) given current market conditions.